Charles A. Rowland Jr - Jan 2, 2025 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
4
Date filed
1/6/2025, 08:13 PM
Previous filing
Jun 10, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Award $0 +18.8K $0.00 18.8K Jan 2, 2025 Common Stock 18.8K $41.12 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.